Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis D Gallos

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 6, 2019
Carbetocin: Worth the extra expense?Ioannis D Gallos, Arri Coomarasamy
Obstetrics and Gynecology|July 2, 2013
Prediction of regression and relapse of endometrial hyperplasia with conservative therapyIoannis D Gallos, Raji Ganesan, Janesh K Gupta
Gynecologic Oncology|April 23, 2013
Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort studyIoannis D Gallos, James Devey, Raji Ganesan, et al.
BMC Women'S Health|July 22, 2022
Outcomes of ovarian transposition in cervical cancer; an updated meta-analysisAlexandros Laios, Mohamed Otify, Argyro Papadopoulou, et al.
Reproductive Biomedicine Online|January 23, 2019
Hydrosalpinx and pregnancy loss: a systematic review and meta-analysisHodaMaaly Harb, Firas Al-Rshoud, Bala Karunakaran, et al.
Human Reproduction (Oxford, England)|March 8, 2013
Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-upIoannis D Gallos, Preeti Krishan, Manjeet Shehmar, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 11, 2011
Current management of endometrial hyperplasia-a survey of United Kingdom consultant gynaecologistsIoannis D Gallos, Olumide Ofinran, M Shehmar, et al.
Human Reproduction (Oxford, England)|August 27, 2013
LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort studyIoannis D Gallos, Preeti Krishan, Manjeet Shehmar, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 5, 2010
Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical studyEmelie Akesson, Ioannis D Gallos, Raji Ganesan, et al.
The Cochrane Database of Systematic Reviews|November 10, 2020
Intravenous versus intramuscular prophylactic oxytocin for the third stage of labourOlufemi T Oladapo, Babasola O Okusanya, Edgardo Abalos, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Best Practice & Research. Clinical Obstetrics & Gynaecology|June 6, 2019
Carbetocin: Worth the extra expense?Ioannis D Gallos, Arri Coomarasamy
Obstetrics and Gynecology|July 2, 2013
Prediction of regression and relapse of endometrial hyperplasia with conservative therapyIoannis D Gallos, Raji Ganesan, Janesh K Gupta
Gynecologic Oncology|April 23, 2013
Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort studyIoannis D Gallos, James Devey, Raji Ganesan, et al.
BMC Women'S Health|July 22, 2022
Outcomes of ovarian transposition in cervical cancer; an updated meta-analysisAlexandros Laios, Mohamed Otify, Argyro Papadopoulou, et al.
Reproductive Biomedicine Online|January 23, 2019
Hydrosalpinx and pregnancy loss: a systematic review and meta-analysisHodaMaaly Harb, Firas Al-Rshoud, Bala Karunakaran, et al.
Human Reproduction (Oxford, England)|March 8, 2013
Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-upIoannis D Gallos, Preeti Krishan, Manjeet Shehmar, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 11, 2011
Current management of endometrial hyperplasia-a survey of United Kingdom consultant gynaecologistsIoannis D Gallos, Olumide Ofinran, M Shehmar, et al.
Human Reproduction (Oxford, England)|August 27, 2013
LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort studyIoannis D Gallos, Preeti Krishan, Manjeet Shehmar, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 5, 2010
Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical studyEmelie Akesson, Ioannis D Gallos, Raji Ganesan, et al.
The Cochrane Database of Systematic Reviews|November 10, 2020
Intravenous versus intramuscular prophylactic oxytocin for the third stage of labourOlufemi T Oladapo, Babasola O Okusanya, Edgardo Abalos, et al.
Pageof 6